Genetic risk factors for arterial ischemic stroke in children: A possible MTHFR and eNOS gene-gene interplay?

Journal of Child Neurology

Volumn 24, Issue 7, 2009, Pages 823-827

  Djordjevic, Valentina ^a   Stankovic, Marija ^a   Brankovic Sreckovic, Vesna ^b   Rakicevic, Ljiljana ^a   Radojkovic, Dragica ^a  

^a INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING   (Serbia)

^b Clinic of Neurology and Psychiatry for Children and Youth   (Serbia)

Author keywords

Arterial ischemic stroke; eNOS G894T; Factor V; MTHFR C677T

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CYTIDINE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROTHROMBIN; THYMIDINE;

ADOLESCENT; ALLELE; ARTERIAL ISCHEMIC STROKE; ARTICLE; BLOOD CLOTTING FACTOR 5 LEIDEN GENE; CEREBROVASCULAR ACCIDENT; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIPEPTIDYL CARBOXYPEPTIDASE GENE; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ADOLESCENT; BRAIN ISCHEMIA; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INTRACRANIAL ARTERIAL DISEASES; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION, MISSENSE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROTHROMBIN; RISK FACTORS; STROKE;

EID: 67949117258     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808330164     Document Type: Article

References (25)

1. Kirkham F., Sebire G., Steinlin M., Strater R. Arterial ischaemic stroke in children. Review of the literature and strategies for future stroke studies. Thromb Haemost. 2004;92:697-706.
2. Hassan A., Markus H. Genetics and ischaemic stroke. Brain. 2000;123:1784-1812.
3. Pezzini A., Grassi M., Zotto E., et al. Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke. 2005;36:533-539.
4. Bertna MR Molecular risk factors for thrombosis. Thromb Haemost. 1999;82:601-609.
5. Komitopoulou A., Platokouki Z., Kapsimali H., Pergantou H., Adamtziki E., Aronis S. Mutations and polymorphisms in genes affecting hemostasis proteins and homocysteine metabolism in children with arterial ischemic stroke. Cerebrovasc Dis. 2006;22:13-20.
6. McColl MD, Chalmers EA, Thomas A., et al. Factor V Leiden, prothrombin 20210G->A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost. 1999;81:690-694.
7. Prengler M., Sturt N., Krywawych S., Surtees R., Liesner R., Kirkham F. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: A potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood. Dev Med Child Neurol. 2001;43:220-225.
8. Malik FS, Lavie CJ, Mehra MR, Milani RV, Re RN Vascular and congenital heart disease. Renin-angiotensin system: Genes to bedside. Am Heart J. 1997;134:514-527.
9. Tuncer N., Tuglular S., Kilic G., Sazci A., Us O., Kara I. Evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischaemic stroke. J Clin Neurosci. 2006;13:224-227.
10. Szolnoki Z., Havasi V., Bene J., et al. Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke. Acta Neurol Scand. 2005;111:29-33.
11. Colombo MG, Paradossi U., Andreassi MG, et al. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem. 2003;49:389-395.
12. Szolnoki Z., Melegh B. Gene-gene and gene-environmental interplay represent specific susceptibility for different types of ischaemic stroke and leukoaraiosis. Curr Med Chem. 2006;13:1627-1634.
13. Djordjevic V., Rakicevic LJ, Spasic M., et al. FV Leiden, FII G20210A, MTHFR C677T mutations and first venous thrombosis during pregnancy and puerperium. Vojnosanit Pregl. 2004;62:201-205.
14. Bonduel M., Sciuccati G., Hepner M., et al. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol. 2003;73:81-86.
15. Barreirinho S., Ferro A., Santos M., et al. Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol. 2003;28:134-138.
16. Nowak-Gottl U., Strater U., Heinecke A., et al. Lipoprotein(a) and genetic polymorphisms of clotting factor V, prothrombin and methylenetethrahydrofolate reductase are risk factor for spontaneous ischemic stroke in childhood. Blood. 1999;31:3678-3682.
17. Akar N., Akar E., Deda G., Sipahi T., Orsal A. Factor V1691 G-A, prothrombin 20210G-A, and methylenetethrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neural. 1999;14:749-751.
18. Koch HG, Nabel P., Junker R., et al. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis. Eur J Pediatr. 1999;158:S113-S116.
19. Veldman B., Spiering W., Doevendans P., et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens. 2002;20:2023-2027.
20. Kluijtmans L., Kastelein J., Lindemans J., et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1997;96:2573-2577.
21. Dhillon B., Badiwala M., Maitland A., Rao V., Li SH, Verma S. Tetrahydrobiopterin attenuates homocysteine induced endothelial dysfunction. Mol Cell Biochem. 2003;247:223-227.
22. Stamler J., Osborne J., Jaraki O., et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308-318.
23. Marini NJ, Gin J., Ziegle J., et al. The prevalence of folateremedial MTHFR enzyme variants in humans. Proc Natl Acad Sci U S A. 2008;105:8055-8060.
24. Kirke PN, Mills JL, Molloy AM, et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: Case-control study. BMJ. 2004;328:1535-1536.
25. Hermans MP, Gala JL, Buysschaert M. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes. Diabet Med. 2006;23:529-536.